Anush Shares and Securities

CLOSE X
Equity 
YOU ARE ON : Home | Equity | Comapny Profile | Summary
Summary
Orchid Pharma Ltd.
BSE CODE: 524372   |   ISIN CODE : INE191A01027
BSE
1811.35
33.35 ( 1.88% )
 
Prev Close ( Rs.)
1778.00
Open ( Rs.)
1778.00
 
High ( Rs.)
1850.00
Low ( Rs.)
1778.00
 
Volume
6090
Week Avg.Volume
7325
 
52 WK High-Low Range
BSE NSE
1811.20
32.75 ( 1.84% )
 
Prev Close ( Rs.)
1778.45
Open ( Rs.)
1778.45
 
High ( Rs.)
1853.85
Low ( Rs.)
1778.45
 
Volume
53320
Week Avg.Volume
60340
 
52 WK High-Low Range
702.75
1853.85
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
You need to upgrade your Flash Player
Competitors
Company NameLast Price (Rs.)Chg (Rs./%)Sales TurnOverVolume
Abbott India29300.05666.55(2.33)1721.76907.00
Neuland Laboratories13712.60266.60(1.98)994.261415.00
Ajanta Pharma3039.45244.10(8.73)270.6822015.00
Caplin Point Lab2596.45199.40(8.32)181.1624692.00
Alkem Laboratories5481.7577.20(1.43)882.86452.00
More>
KEY PERSONNEL & ADDRESS
Chairman
Ram Gopal Agarwal
Managing Director
Manish Dhanuka
Company Secretary
Kapil Dayya
Registered Office :
Plot Nos. 121-128, 128 A-133, 138-151, 159-164,Sidco Industrial Estate,Alathur, Chengalpattu,
Tamil Nadu-603110 .
Phone :
044-44-2744 4471/72/73  
E-mail :
corporate@orchidpharma.com / nikitak@orchidpharma.com
URL
www.orchidpharma.com
 
News On ORCHPHARMA
12/11/2024
Orchid Pharma informs about ne...
07/08/2024
Orchid Pharma submits analyst ...
01/07/2024
Orchid Pharma gains on partner...
28/06/2024
Orchid Pharma partners with Ci...
More >
Financials
QUARTERLY (Sep 24)
Net Profit( Rs . In Cr) 256.27
Gross Profit( Rs . In Cr) 256.27
Operating Profit( Rs . In Cr) 375.48
Net Sales( Rs .In Cr) 2226.99
More>
MF Holding Details
Scheme NameMkt value (In Cr.)
Quant Small Cap Fund...474.04
Invesco India Contra...183.14
Nippon India Pharma ...85.21
Invesco India ELSS T...49.71
UTI Small Cap Fund-R...47.23
Invesco India Smallc...46.40
JM Flexicap Fund-Reg...39.13
More>
Attention Investors: "Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors. "
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account
Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Exchange / CDSL on the same day.........issued in the interest of investors.
SEBI REGN NO: INZ000271235 | DP~IN-DP 672-2022 | Member ID : NSE :14453 | BSE: 6281 | MCX-SX: 11280 |SCM F&O: M50171 | AMFI: 2110
Segregation and Monitoring of Collateral at Client Level with reference to NCL circulars NCL/CMPL/49348 dated August 20, 2021, NCL/CMPL/49640 dated September 17, 2021 and NCL/CMPL/49764 dated September 29, 2021 on the captioned subject
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 dated August 31, 2020 and other guidelines issued from time to time in this regard 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors. "

BSE
×